Literature DB >> 1931437

The role of transferrin and citrate in cellular uptake of aluminium.

S J McGregor1, J H Brock, D Halls.   

Abstract

The ability of human erythroleukaemia K562 cells to take up aluminium from Al-transferrin and Al-citrate has been examined. Uptake from Al-transferrin was dose-dependent over the range 68-544 ng/ml of aluminium, and increased over a 12-day period. In contrast, uptake from Al-citrate was low even at an aluminium concentration of 6800 ng/ml and did not increase over time. Neither form of aluminium greatly affected cell growth. It is concluded that Al-transferrin, rather than Al-citrate, is the physiologically relevant form of this metal with respect to cellular uptake, but that any metabolic abnormalities induced by aluminium do not affect proliferation of this cell line.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931437     DOI: 10.1007/bf01141310

Source DB:  PubMed          Journal:  Biol Met        ISSN: 0933-5854


  14 in total

1.  Spectroscopic evidence for perturbation of tryptophan in Al(III) and Ga(III) binding to ovotransferrin and human serum transferrin.

Authors:  Y Tomimatsu; J W Donovan
Journal:  FEBS Lett       Date:  1976-12-01       Impact factor: 4.124

2.  Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells.

Authors:  S J McGregor; M L Naves; R Oria; J K Vass; J H Brock
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Aluminum uptake by neuroblastoma cells.

Authors:  B Shi; A Haug
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

4.  Role of iron metabolism in absorption and cellular uptake of aluminum.

Authors:  J B Cannata; I Fernández-Soto; M J Fernández-Menendez; J L Fernández-Martín; S J McGregor; J H Brock; D Halls
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

5.  Aluminum access to the brain: a role for transferrin and its receptor.

Authors:  A J Roskams; J R Connor
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Approaches to the standardization of serum unsaturated iron-binding capacity.

Authors:  G Grahm; G W Bates
Journal:  J Lab Clin Med       Date:  1976-09

7.  Plasma aluminum is bound to transferrin.

Authors:  G A Trapp
Journal:  Life Sci       Date:  1983-07-25       Impact factor: 5.037

8.  Transferrin binding of Al3+ and Fe3+.

Authors:  R B Martin; J Savory; S Brown; R L Bertholf; M R Wills
Journal:  Clin Chem       Date:  1987-03       Impact factor: 8.327

9.  Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain.

Authors:  G Farrar; P Altmann; S Welch; O Wychrij; B Ghose; J Lejeune; J Corbett; V Prasher; J A Blair
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

Review 10.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

View more
  3 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Hippocampal tin, aluminum and zinc in Alzheimer's disease.

Authors:  F M Corrigan; G P Reynolds; N I Ward
Journal:  Biometals       Date:  1993       Impact factor: 2.949

3.  (13)C heteronuclear NMR studies of the interaction of cultured neurons and astrocytes and aluminum blockade of the preferential release of citrate from astrocytes.

Authors:  Shunsuke Meshitsuka; David A Aremu
Journal:  J Biol Inorg Chem       Date:  2007-11-15       Impact factor: 3.358

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.